about
The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistanceNovel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteinsGenetically Engineered Phages: a Review of Advances over the Last DecadeBacteriophages as Weapons Against Bacterial Biofilms in the Food IndustryBiocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and EndolysinsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsCrystal structure of the antimicrobial peptidase lysostaphin fromStaphylococcus simulansBacteriophages and phage-derived proteins--application approachesGMEnzy: a genetically modified enzybiotic databaseBiochemical Characterization and Validation of a Catalytic Site of a Highly Thermostable Ts2631 Endolysin from the Thermus scotoductus Phage vB_Tsc2631Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.Bacteriophages and Their Immunological Applications against Infectious Threats.Crystal Structure of the CTP1L Endolysin Reveals How Its Activity Is Regulated by a Secondary Translation Product.Proteomic response of β-lactamases-producing Enterobacter cloacae complex strain to cefotaxime-induced stress.Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaEfficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.Metagenomic Approaches to Assess Bacteriophages in Various Environmental Niches.Bacterial ghosts as adjuvants: mechanisms and potential.Finding alternatives to antibiotics.Molecular characterization of a novel temperate sinorhizobium bacteriophage, ФLM21, encoding DNA methyltransferase with CcrM-like specificity.Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococciIsolation and Genomic Characterization of the T4-Like Bacteriophage PM2 Infecting Pectobacterium carotovorum subsp. carotovorum.Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood.Comparative analysis of multiple inducible phages from Mannheimia haemolytica.Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme.Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.Diversity in a Polymicrobial Community Revealed by Analysis of Viromes, Endolysins and CRISPR Spacers.RETRACTED: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative BacteriaTriple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureusLysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammationWall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile.Phages of Listeria offer novel tools for diagnostics and biocontrol.Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applicationsNew perspectives in the management of Pseudomonas aeruginosa infections.
P2860
Q21089782-CE761B2D-D9E2-4652-922B-707F834104C3Q24609778-D9947E7E-4C0D-4320-836C-4D0D165F42B9Q26744156-48B4CCA0-5264-4B71-A10C-FCEDD1176FA7Q26745094-A4242857-AF80-4DD2-81B2-AC8C21FE2096Q26752523-749BA3E9-E939-482F-8266-62682963B65BQ26781115-936AC39E-AE14-4E82-8E50-7D27187FF37AQ27684730-14670403-6E1A-4717-A77E-FB43E1E9585DQ28082731-BF3C7A94-7FB0-4022-AD63-F129F71BB3D0Q28541518-F4963A23-3928-434B-902C-5336E4A80ABAQ28548052-BF3E2F3C-E740-4331-8ACA-1EED9C54F468Q30009348-004195A5-0C00-4D52-A797-1D537DAF4D91Q30234522-0A813590-8298-4D85-8736-31A7B511FE19Q30382656-24882334-23C4-4ACB-A281-24101CD8E8D4Q30387903-DC6BF931-3E2B-4431-8152-A7CACCBE07C5Q30581467-B5038110-8615-4EE1-9B51-8C431F7CAA6BQ30761262-0076271E-C23C-4FC8-ADE8-F033B05ACF79Q32183798-9C32FCC2-D083-46DB-A3F9-09161782A719Q33830398-0769D2B5-0F3C-45E7-AE07-8AF02C53E1BFQ34426004-17464A68-839C-4D2F-A93C-EA2C819BFDF4Q34594463-4561884C-D414-4124-AB22-32DDC2831B8AQ34762253-FE9A4766-939E-4C8E-89ED-9F1A00CE4FDBQ35158325-2F56BDFF-AFD6-4B59-BE7E-8B7EE3765ED0Q35168482-E74BE366-BAD3-416C-B7D2-FDEADF86D3E1Q35432724-69612522-DE71-49CA-A837-86A4C030F8D7Q35689447-930F6331-6465-43B7-8DD0-F949623C74F2Q35759419-56F1D69D-61C4-42AD-887A-3D5845BA514EQ35808662-FB3709D1-9203-4539-AF8F-7B67213669C6Q35808669-AE4B7274-956B-44B9-BD74-BD5496F0093CQ35871785-BF76F1B8-2768-4959-A471-9CF5FF24FE60Q36070204-BBA96BBE-AD7A-447A-AECE-896BEE911BE1Q36119542-7E08DD2D-A4DD-48C8-BE96-86B6A3492000Q36128097-3B2BFC00-189B-4EF2-ABAA-AF480BABAA59Q36270490-6B058EC4-8DF5-4FA9-99B6-632F22940309Q36309634-345E931D-50F9-44E7-B650-4AAE1A5FA702Q36845812-89F922E8-CE3B-4F17-91D4-93B8D316BE86Q37072798-5F474F3D-A588-4A97-9C9B-89A50107270BQ37348810-5BBA3EF4-A376-4A02-8772-1B52EC595990Q37707618-7E8ECF94-B2DA-4A4A-8348-AD02E7B14358Q38197928-DA103A35-9F11-413A-B1E7-A82377BB1F3CQ38243221-E4AAABB0-1F79-42FA-A537-3BDFBF94CD8E
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Bacteriophage endolysins as novel antimicrobials.
@ast
Bacteriophage endolysins as novel antimicrobials.
@en
Bacteriophage endolysins as novel antimicrobials.
@nl
type
label
Bacteriophage endolysins as novel antimicrobials.
@ast
Bacteriophage endolysins as novel antimicrobials.
@en
Bacteriophage endolysins as novel antimicrobials.
@nl
prefLabel
Bacteriophage endolysins as novel antimicrobials.
@ast
Bacteriophage endolysins as novel antimicrobials.
@en
Bacteriophage endolysins as novel antimicrobials.
@nl
P2093
P2860
P356
P1433
P1476
Bacteriophage endolysins as novel antimicrobials.
@en
P2093
David M Donovan
Martin J Loessner
Mathias Schmelcher
P2860
P304
P356
10.2217/FMB.12.97
P577
2012-10-01T00:00:00Z